Short answer
Teladoc Health, Inc. (TDOC) filed an 8-K current report with the SEC on October 28, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Third-quarter 2026 financial results announced by Teladoc Health.
Teladoc Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Third-quarter 2026 financial results announced by Teladoc Health
- Press release Exhibit 99.1 contains the detailed operating and financial results
- Results provide an updated view of Teladoc’s performance, trends, and outlook for investors
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue fell 3% to $605.1M, while adjusted EBITDA rose 14% to $79.4M, signaling margin-focused execution despite slower demand
- Integrated Care grew 2% to $398.5M, with adjusted EBITDA margin improving to 18.8%, offsetting weakness elsewhere
- BetterHelp revenue declined 13% to $206.6M as paying users fell 12%, highlighting continued cash-pay deterioration despite insurance expansion
- Free cash flow improved to $75.9M in Q3, but nine-month free cash flow fell to $85.4M from $113.5M
- Full-year outlook targets revenue $2,395-$2,441M, adjusted EBITDA $277-$303M, and free cash flow $135-$165M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Teladoc Health, Inc. 8-K filings
Get the next TDOC 8-K as it lands
Follow TDOC for push alerts, or ask the research agent what this filing means.